Psychotherapy/counseling for opiate addicts: strategies for use in different treatment settings.
The authors review evidence from outcome studies of psychotherapy for opiate addicts and make recommendations regarding the use of psychotherapy on the basis of the findings. The place of psychotherapy is evaluated for three types of treatment settings: outpatient drug-free treatment, narcotic antagonist treatment, and methadone maintenance. The heterogeneity of opiate addicts is emphasized, as is the need for multidimensional assessment of clients in order to maximize the effectiveness of psychotherapies offered. In each of the treatment settings evaluated, psychotherapy appears to be most promising for a subgroup of those seen. For outpatient drug-free treatment, psychotherapy appears to be most useful for the new client with no treatment history, the successful client graduating from a more intensive program, the client who has temporarily relapsed, and the client leaving jail or a hospital. In a narcotic antagonist program, psychotherapy appears to be most useful for clients entering the program from illicit heroin use and not for those switching from methadone maintenance to a narcotic antagonist program. Moreover, in the maintenance phase of the program, preliminary evidence suggests the value of family therapy for aiding treatment retention. Regarding psychotherapy in the context of a methadone maintenance program, it appears to be best reserved for those addicts who present to treatment with relatively severe levels of psychiatric symptoms.
D001521:Behavior Therapy / Q000379:methods; D003071:Cognition; D003131:Combined Modality Therapy; D003376:Counseling; D006801:Humans; D007171:Implosive Therapy; D001523:Mental Disorders / Q000150:complications; D008691:Methadone / Q000627:therapeutic use; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D009293:Opioid-Related Disorders / Q000523:psychology / Q000534:rehabilitation / Q000628:therapy*; D010349:Patient Compliance; D011613:Psychotherapy / Q000379:methods; D011614:Psychotherapy, Brief; D011615:Psychotherapy, Group; D011897:Random Allocation; D012008:Recurrence
D009292:Narcotic Antagonists; D009271:Naltrexone; D008691:Methadone